Accelerate Diagnostics, Inc.

AXDXNASDAQHealthcare

$0.03

+$0.00(+0.00%)

Market Cap$859918

P/E Ratio—

52W High$2.09

52W Low$0.01

Avg Volume1.9M

Open$0.08

Beta0.22

Net Income Financials Revenue

Accelerate Diagnostics, Inc. (AXDX) Net Income & Profit History

Annual & trailing net income, net margin, YoY change, and peer profitability context.

AXDX · net income · updated Jun 9, 2026

Core profitability metrics

AXDX · net income · margin · TTM · CAGR

Net income was −$50.0M for FY2024 (fiscal year ending 2024-12-31), up 18.8% year-over-year. Net profit margin was -427.8%. Based on available data, Accelerate Diagnostics, Inc. has been profitable since at least 2010.

FY2024 Net Income−$50.0M▲ +18.8% YoY

Trailing 12M (TTM)−$50.0Mtrailing 4 quarters sum

Net Profit Margin-427.8%−$50.0M ÷ $11.7M

YoY Change+18.8%—

5-Year CAGRN/AN/A — contains loss years

FormulaNet Margin = Net Income ÷ Revenue × 100TTM = trailing 4 quarters sumCAGR → N/A if either endpoint ≤ 0

Source: FMP /income-statement · US GAAP · USDUpdated: Jun 9, 2026

Annual net income history

Net Income (bars) · Net Profit Margin % (line)

Net IncomeNet LossNet Margin %★ First Profit: 2010

▸ FMP /income-statement · Annual · AXDX net income history · AXDX profit margin

Annual net income data

AXDX · net income history · annual / quarterly

Fiscal YearNet IncomeYoY ChangeNet MarginRevenue

FY2024Loss−$50.0M▲ +18.8%-427.8%$11.7M

FY2023Loss−$61.6M▲ +1.4%-511.0%$12.1M

FY2022Loss−$62.5M▲ +19.6%-490.1%$12.8M

FY2021Loss−$77.7M▲ +0.6%-659.5%$11.8M

FY2020Loss−$78.2M▲ +7.2%-700.5%$11.2M

Net income vs peers (Healthcare)

AXDX vs peers · net income

#CompanyNet IncomeYoYNet MarginRelative

Accelerate Diagnostics, Inc.YOU

AXDX

−$50.0M+18.8%-427.8%

Loss

Eli Lilly and Company

LLY

$20.64B+94.9%31.7%

77%

UnitedHealth Group Incorporated

Healthcare · Sorted by Net Income · FMP /income-statementFull Net Income Rankings →

About Net Income & Methodology

Accelerate Diagnostics, Inc. (AXDX) reported net income of −$50.0M for FY2024 (fiscal year ending 2024-12-31), up 18.8% year-over-year. The net profit margin was -427.8% — meaning the company kept $-4.28 of every dollar of revenue as profit.

Based on available data, Accelerate Diagnostics, Inc. has been profitable since at least 2010. Net income reached a peak of $641,747 in FY2010. Data available for 15 fiscal years.

Accelerate Diagnostics, Inc.'s net profit margin was -427.8% for FY2024, based on the latest annual results.

Investors sometimes search for "Accelerate Diagnostics, Inc. net worth" — the company's market capitalization is a separate figure from AXDX net income. Data sourced from FMP /income-statement · US GAAP · USD.

Figures tie to SEC 10-K/10-Q and FMP /income-statement where noted.

Revenue Financial statements Earnings Forecast Price history Market cap Free cash flow

Frequently asked questions

AXDX net income · 4 questions

Accelerate Diagnostics, Inc. is not currently profitable on an annual basis. The company reported a net loss of $50.0M for FY2024.

is AXDX profitabledoes AXDX make a profitAXDX profitabilityAXDX profitable company

▸ Source: FMP /income-statement · GAAP · Accelerate Diagnostics, Inc. · Accelerate Diagnostics, Inc. SEC 10-K & 10-Q filings · US GAAP · Last updated: Jun 9, 2026